StockDriftsStockDriftsTop 50 Act Capital Partners L P Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CVX | CHEVRON CORPORATION | 10.1% | 75.0K | $15.3M | new | $184.99(+14.93%) | 2026-09-30 | |
| KRYS | KRYSTAL BIOTECH INC | 9.21% | 42.0K | $14.0M | new | $352.12(-14.55%) | 2026-09-30 | |
| TGTX | TG THERAPEUTICS INC | 8.73% | 237.2K | $13.2M | new | $55.36(+8.07%) | 2026-09-30 | |
| AMZN | AMAZON COM INC | 6.98% | 42.5K | $10.6M | new | $243.74(+6.38%) | 2026-09-30 | |
| ABVX | ABIVAX SA | 5.55% | 85.0K | $8.4M | new | $116.14(-27.52%) | 2026-09-30 | |
| VKTX | VIKING THERAPEUTICS INC | 4.73% | 220.2K | $7.2M | new | $35.80(-27.97%) | 2026-09-30 | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 4.06% | 94.0K | $6.2M | new | $73.48(-20.85%) | 2026-09-30 | |
| NKTR | NEKTAR THERAPEUTICS | 3.61% | 90.4K | $5.5M | new | $65.18(-42.84%) | 2026-09-30 | |
| TSLA | TESLA INC | 3.46% | 14.8K | $5.3M | new | $387.71(-7.61%) | 2026-09-30 | |
| CELC | CELCUITY INC | 3.08% | 58.6K | $4.7M | new | $92.07(-30.44%) | 2026-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Act Capital Partners L P reports $153.96M in US-listed equity holdings across 56 positions in its most recent 13F filing. Its largest disclosed positions are CVX (10.1%), KRYS (9.2%) and TGTX (8.7%). The top 20 holdings account for 76.74% of reported assets. Figures reflect the Q3 2026 filing.
Sign up free to track Act Capital Partners L P, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Act Capital Partners L P’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1875197). View Act Capital Partners L P’s 13F filings on SEC